These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 475904)

  • 1. [Technical-administrative aspects of the registration of pharmaceutical specialities].
    Marconi M; Battaglino G
    Boll Chim Farm; 1979 Mar; 118(3):118-34. PubMed ID: 475904
    [No Abstract]   [Full Text] [Related]  

  • 2. [Pharmaceutical specialities: definitions and rules for manufacturing and marketing in Italy].
    Germani C; Montanari L; Petraroja A
    Boll Chim Farm; 1979 Mar; 118(3):135-43. PubMed ID: 475905
    [No Abstract]   [Full Text] [Related]  

  • 3. [New pharmaceutical legislation in Italy and Federal Republic of Germany in relation to European Economic Community directives].
    Cavatorta L
    Boll Chim Farm; 1979 Mar; 118(3):144-62. PubMed ID: 475906
    [No Abstract]   [Full Text] [Related]  

  • 4. [Preclinical documentation for the registration of drugs].
    Cantone A
    Boll Chim Farm; 1971 Oct; 110(10):579-81. PubMed ID: 5143356
    [No Abstract]   [Full Text] [Related]  

  • 5. [Guidelines on the use of medicinal plants].
    Battaglino G; Quercia V
    Boll Chim Farm; 1978 May; 117(5):251-7. PubMed ID: 743374
    [No Abstract]   [Full Text] [Related]  

  • 6. [Technicoscientific evolution and current direction of the standards regulating drug registration in Italy and in the European Economic Community].
    Battaglino G
    Boll Chim Farm; 1978 Jun; 117(6):313-24. PubMed ID: 743380
    [No Abstract]   [Full Text] [Related]  

  • 7. [The new norms decreed by the legislative dirrective 91-93 CCE].
    Neri M; Palazzo S
    Boll Chim Farm; 1998 Feb; 137(2):31-4. PubMed ID: 9595832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Proposals for the legal control of the testing and introduction of drugs based on a comparison of drug laws in other countries].
    Burow W; Lüllmann H
    Schriftenr Geb Off Gesundheitswes; 1971; 31():1-64. PubMed ID: 5153578
    [No Abstract]   [Full Text] [Related]  

  • 9. [Official inspections of a pharmaceutical plant during the registration of new products].
    De Martiis F; Fontani F; Zanotti-Gerosa A
    Boll Chim Farm; 1982 Jul; 121(7):319-27. PubMed ID: 7150440
    [No Abstract]   [Full Text] [Related]  

  • 10. Towards a more rational regulation of the development of new medicines. Report of a European workshop held in Sestri Levante, Italy, September 28-30, 1976.
    Eur J Clin Pharmacol; 1977 Mar; 11(3):233-8. PubMed ID: 852499
    [No Abstract]   [Full Text] [Related]  

  • 11. Extra-label drug use--pharmaceutical industry view.
    Welser JR
    J Am Vet Med Assoc; 1993 May; 202(10):1635-42;discussion 1654-8. PubMed ID: 8514571
    [No Abstract]   [Full Text] [Related]  

  • 12. [The birth of new drugs].
    Petrányi G
    Orv Hetil; 1968 May; 109(21):Suppl:1-6. PubMed ID: 5720715
    [No Abstract]   [Full Text] [Related]  

  • 13. WHO Expert Committee on specifications for pharmaceutical preparations.
    World Health Organ Tech Rep Ser; 1996; 863():1-194. PubMed ID: 8952445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The problem of pesticide and heavy metal residues in plant-derived drugs used in the pharmaceutical industry].
    Lorusso S; Camoni I; Chiacchierini E
    Nuovi Ann Ig Microbiol; 1985; 36(3):169-80. PubMed ID: 3842759
    [No Abstract]   [Full Text] [Related]  

  • 15. [Standardization as a basis planning and administration in drug industry and pharmacy (II)].
    Wagler M
    Pharm Prax; 1970; 7():151-3. PubMed ID: 5469874
    [No Abstract]   [Full Text] [Related]  

  • 16. Negotiating reality: the construction of enforceable pharmaceutical standards.
    Parrish RH
    Food Drug Law J; 2002; 57(3):457-74. PubMed ID: 12710406
    [No Abstract]   [Full Text] [Related]  

  • 17. [Responsibility for drug testing and control].
    Büchi J
    Pharm Acta Helv; 1968 Sep; 43(9):619-27. PubMed ID: 5718866
    [No Abstract]   [Full Text] [Related]  

  • 18. WHO Expert Committee on Specifications for Pharmaceutical Preparations.
    World Health Organization
    World Health Organ Tech Rep Ser; 2005; 929():1-142, backcover. PubMed ID: 16353684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Guidelines for introducing new drugs for medical use in Poland and control of their quality].
    Danysz A
    Pol Tyg Lek; 1984 Dec 17-31; 39(51-52):1673-4. PubMed ID: 6522321
    [No Abstract]   [Full Text] [Related]  

  • 20. [Large scale "monitoring" for drug safety].
    Ghione M
    Boll Chim Farm; 1971 Oct; 110(10):573-8. PubMed ID: 5143355
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.